NewsBenzingaCellectar Biosciences公布病例研究结果,展示一名接受Iopofosine I-131治疗的重度预处理弥漫大B细胞淋巴瘤患者获得持久完全缓解 Cellectar Biosciences公布病例研究结果,展示一名接受Iopofosine I-131治疗的重度预处理弥漫大B细胞淋巴瘤患者获得持久完全缓解 Benzinga 2026.10.27 11:16 (GMT+0) Open on Benzinga Other news GlobalFoundries to Test Atlas Humanoids in Early 2027 Coinbase Account Connection Opens to All ChatGPT Users NVIDIA Earnings Preview: Management Transition and Whether Q4 Revenue Guidance Can Break Through $125 Billion Nvidia’s first big move after Jensen Huang’s exit targets national security Bitwise Launches AI Cybersecurity ETF ZDAY, Focusing on Companies Defending Against AI Attacks and Securing AI Systems Michael Burry Is Betting on an AI Stock Selloff. I’d Rather Buy the Dip.
NVIDIA Earnings Preview: Management Transition and Whether Q4 Revenue Guidance Can Break Through $125 Billion
Bitwise Launches AI Cybersecurity ETF ZDAY, Focusing on Companies Defending Against AI Attacks and Securing AI Systems